| __timestamp | MiMedx Group, Inc. | Travere Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 118223000 | 28203205 |
| Thursday, January 1, 2015 | 187296000 | 99892000 |
| Friday, January 1, 2016 | 245015000 | 133591000 |
| Sunday, January 1, 2017 | 321139000 | 154937000 |
| Monday, January 1, 2018 | 359111000 | 164246000 |
| Tuesday, January 1, 2019 | 299255000 | 175338000 |
| Wednesday, January 1, 2020 | 248234000 | 198321000 |
| Friday, January 1, 2021 | 258615000 | 227490000 |
| Saturday, January 1, 2022 | 267841000 | 212018000 |
| Sunday, January 1, 2023 | 321477000 | 145238000 |
Infusing magic into the data realm
In the dynamic world of biotechnology, revenue growth is a key indicator of a company's success and potential. Over the past decade, Travere Therapeutics, Inc. and MiMedx Group, Inc. have showcased contrasting trajectories in their annual revenue growth.
MiMedx Group, Inc. has demonstrated a robust growth pattern, with its revenue peaking in 2018 at approximately 360 million USD. Despite a dip in 2019, the company rebounded, achieving a 21% increase by 2023 compared to its 2014 figures.
Conversely, Travere Therapeutics, Inc. experienced a more volatile journey. Starting with a modest revenue in 2014, the company saw a significant rise, reaching its zenith in 2021. However, by 2023, its revenue had decreased by 36% from its peak.
These trends highlight the unpredictable nature of the biotech industry, where innovation and market dynamics play pivotal roles.
Merck & Co., Inc. vs MiMedx Group, Inc.: Examining Key Revenue Metrics
Revenue Insights: Sanofi and MiMedx Group, Inc. Performance Compared
Who Generates More Revenue? Bristol-Myers Squibb Company or MiMedx Group, Inc.
Revenue Showdown: Vertex Pharmaceuticals Incorporated vs MiMedx Group, Inc.
Annual Revenue Comparison: Regeneron Pharmaceuticals, Inc. vs MiMedx Group, Inc.
Biogen Inc. vs Travere Therapeutics, Inc.: Examining Key Revenue Metrics
Comparing Revenue Performance: BeiGene, Ltd. or Travere Therapeutics, Inc.?
Who Generates More Revenue? BioMarin Pharmaceutical Inc. or Travere Therapeutics, Inc.
Revenue Insights: Sarepta Therapeutics, Inc. and MiMedx Group, Inc. Performance Compared
Alkermes plc and MiMedx Group, Inc.: A Comprehensive Revenue Analysis
Ligand Pharmaceuticals Incorporated or Travere Therapeutics, Inc.: Who Leads in Yearly Revenue?
Novavax, Inc. vs MiMedx Group, Inc.: Annual Revenue Growth Compared